Efficacy of Intravitreal Aflibercept Monotherapy for Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration: A Prospective Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2019
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 19 Jan 2019 Status changed from active, no longer recruiting to completed.
- 04 Jan 2019 Planned End Date changed from 1 Dec 2019 to 1 Mar 2019.
- 04 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2019.